Evogliptin

Evogliptin

Cat Number
API1222102295
CAS Number
1222102-29-5

If you have any other questions, please contact our experts.

CAS Number
1222102-29-5
Description
Evogliptin (DA-1229) is a DPP4 inhibitor with oral activity. Evogliptin has significant and lasting hypoglycemic effect in mouse model. Evogliptin inhibits the production of the fibrosis and inflammatory in hepatocytes signals by inducing autophagy. Evogliptin can be used to study type 2 diabetes, chronic liver inflammation, osteoporosis and renal impairment.
Molecular Formula
C19H26F3N3O3
Molecular Weight
401.42
You Might Also Like
Ciprofloxacin monohydrochloride
Ciprofloxacin monohydrochloride

Cat NO.: API93107085
CAS NO.: 93107-08-5

View Details
Citalopram hydrobromide
Citalopram hydrobromide

Cat NO.: API59729327
CAS NO.: 59729-32-7

View Details
Fluticasone Propionate-d5
Fluticasone Propionate-d5

Cat NO.: API1093258286
CAS NO.: 1093258-28-6

View Details
5\'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2\',3\'-diacetate
5\'-Deoxy-5-fluoro-N-[(pentyloxy)carbonyl]cytidine 2\',3\'-diacetate

Cat NO.: API162204208
CAS NO.: 162204-20-8

View Details
HOURS

Daily: 9.30 AM–6.00 PM
Sunday : 9.30 AM–1.00 PM
Holidays: Closed

Member of
dcat
CERTIFICATION
dcat
dcat dcat dcat dcat
Contact Us
USA

Tel:
Email:
Address:

 
Denmark

Tel:
Email:
Address:

WhatsAPP
WhatsAPP (Sales #1)
WhatsAPP
WhatsAPP (Sales #2)
WhatsAPP
WhatsAPP (Sales #3)
Privacy Policy | Cookie Policy
Copyright © Protheragen. All Rights Reserved.

WhatsAPP
Top